NSCLC HER3-DXd Breakthrough? Insights from Resistant Cases – HERTHENA-Lung02 Results Lung Cancer Treatment 3 Mins Read This report examines the NSCLC HER3-DXd breakthrough. It focuses on its potential impact on patients with resistant EGFR-mutated non-small cell…
Phase 3 Study 309/KEYNOTE-775: Advanced Endometrial Cancer-ESMO 2023 Other 2 Mins Read By. Corina Dutcus, MDDate. November 01, 2023Corina Ductus, MD, a medical doctor and the Senior Vice President of Clinical Development…
